Author

Daniele Mauro

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.

In this real-world emulated multicentre clinical trial, bDMARDs showed comparable overall trajectories of short-term effectiveness and long-term treatment persistence in PsA and the identification of partially distinct response patterns may support a more individualised approach to bDMARD selection.

P. Ruscitti, F. Masedu, I. Pantano et al. · Annals of the Rheumatic Dise... · 0 citations

Open access Sep 2026

Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort

Risankizumab was associated with clinical benefit and acceptable treatment persistence, even if larger studies are needed, even if larger studies are needed.

Francesco Caso, E. Celletti, I. Pantano et al. · Expert Opinion on Biological... · 0 citations

Review Open access Sep 2026

Difficult-to-treat systemic lupus erythematosus: from refractory disease to a multidimensional clinical trajectory.

Difficult-to-treat (D2T) systemic lupus erythematosus (SLE) is increasingly recognised in clinical practice but is still conceptually underdeveloped. In contrast to rheumatoid arthritis and psoriatic arthritis, for which formal D2T frameworks have been proposed, SLE still lacks a multidimensional model capable of captu...

S. Gandolfo, Ioannis Parodis, D. Mauro et al. · Journal of Autoimmunity · 0 citations